seekingalpha.com
The Arena Group Holdings, Inc. (AREN) Q4 2025 Earnings Call Transcript
The Arena Group Holdings, Inc. (AREN) Q4 2025 Earnings Call Transcript
The Arena Group Holdings, Inc.ARENNYSE
Loading
Latest News
Loading news...
businesswire.com
The Arena Group Reports Q4 and Full Year 2025 Results, Marking First Full Year of Positive Net Income and Major Debt Reduction
NEW YORK--(BUSINESS WIRE)--The Arena Group Holdings, Inc. (NYSE American: AREN) (“The Arena Group” or “Arena”), a brand, data, and IP company home to many of the nation's most recognizable brands, including Parade, TheStreet, Men's Journal, Athlon Sports, ShopHQ and the Adventure Network (including Surfer, Powder, Bike Magazine and more), today announced financial results for the three months ending December 31, 2025 (“Q4 2025”) and the year ended December 31, 2025 (“FY 2025”). Financial Highli.
benzinga.com
EXCLUSIVE: Bull in the Arena—Webull CEO Says Serious Retail Traders are the Moat
Webull Corp. (NASDAQ: BULL) heads into its fourth‑quarter report on Wednesday with analysts looking for another strong top‑line print and continued profitability, as CEO Anthony Denier leans on a platform "built for the active, self-directed investor from day one."
businesswire.com
The Arena Group to Host Fourth Quarter and Full-Year 2025 Financial Results Conference Call on Monday, March 16, 2026
NEW YORK--(BUSINESS WIRE)--The Arena Group Holdings, Inc. (NYSE American: AREN), the brand, data and IP company that builds, acquires and scales high-performing digital assets—home to many of the nation's most recognizable brands including TheStreet, Parade, Men's Journal, Athlon Sports, Surfer, ShopHQ and more—today announced that it will release its financial results for the fourth quarter and fiscal year ended December 31, 2025, on Monday, March 16, 2026, following the close of the market. C.
investors.com
Beyond Nvidia Earnings, This IPO Leader Enters The Arena
While Wall Street awaits Nvidia earnings, IPO Leader Amer Sports also enters the spotlight alongside the AI giant on Wednesday.
fool.com
T-Mobile US: A Strong Contender in the Telecom Arena
Explore the exciting world of T-Mobile US (TMUS 2.90%) with our contributing expert analysts in this Motley Fool Scoreboard episode. Check out the video below to gain valuable insights into market trends and potential investment opportunities!
fool.com
Arena Capital Sells $35 Million of Diebold Nixdorf Stock
Arena Capital sold its entire Diebold Nixdorf stake, or 611,495 shares reported in its previous 13F. Quarter-end position value fell by $35 million, reflecting both trading and price changes.
etftrends.com
Fidelity Enters Active CLO Arena With 2 New ETFs
With the fixed income market flush with uncertainty, yield may be harder to attain. This is where collateralized loan obligations (CLOs) can offer opportunities.
businesswire.com
TravelHost Releases Guide to the Top Romantic Getaways in Each U.S. State, Perfect for a Long-Weekend Valentine's Trip
NEW YORK--(BUSINESS WIRE)--TravelHost, the premier travel destination publication, released its comprehensive guide to 50 of their top destinations for a long, romantic weekend getaway. From coast to coast, TravelHost has the perfect destinations for couples to find their next adventure, no matter where they live. With Valentine's Day on the horizon, this guide offers couples plenty of inspiration for memorable getaways; from Southern charm and historic streets to snow‑covered mountains and des.
globenewswire.com
Señorita and RYTHM Make History as the First THC Beverages Available at a Major U.S. Arena
Partnership marks a first for the United Center and establishes RYTHM, Inc. as the venue's Official THC Sponsor Partnership marks a first for the United Center and establishes RYTHM, Inc. as the venue's Official THC Sponsor
fool.com
Eli Lilly: A Strong Player in the Pharmaceutical Arena
Explore the exciting world of Eli Lilly (LLY +0.53%) with our contributing expert analysts in this Motley Fool Scoreboard episode. Check out the video below to gain valuable insights into market trends and potential investment opportunities!
globenewswire.com
Incannex Healthcare Wins Research and Development Award for Obstructive Sleep Apnea Program in the 2025 Clinical Trials Arena Excellence Awards
MELBOURNE, Australia and NEW YORK, Jan. 15, 2026 (GLOBE NEWSWIRE) -- Incannex Healthcare Inc. (Nasdaq: IXHL), a clinical-stage biopharmaceutical company developing innovative combination therapies, today announced that it has been honored with the Research and Development Award in the Respiratory Disorders category of the 2025 Clinical Trials Arena Excellence Awards for its work advancing IHL-42X, the Company's oral fixed-dose combination product candidate for the treatment of obstructive sleep apnea (OSA). The Clinical Trials Arena Excellence Awards is an independent recognition program powered by GlobalData's business intelligence, in which researchers, journalists, and artificial intelligence analyze more than one billion datasets annually to identify and rank leading companies and achievements across more than 200 countries.
defenseworld.net
The Arena Group (NYSE:AREN) Trading Up 3.3% – Still a Buy?
The Arena Group Holdings, Inc. (NYSE: AREN - Get Free Report) shares shot up 3.3% during trading on Wednesday. The stock traded as high as $4.47 and last traded at $4.35. 53,158 shares were traded during trading, a decline of 38% from the average session volume of 85,440 shares. The stock had previously closed at
businesswire.com
Xanterra Travel Collection® and T-Mobile Arena Announce New Multi-Year Partnership Putting the Spotlight On The Oasis at Death Valley
LAS VEGAS--(BUSINESS WIRE)--Xanterra Travel Collection® and T-Mobile Arena Announce New Multi-Year Partnership Putting the Spotlight On The Oasis at Death Valley.
businesswire.com
The Arena Group Announces Debt Maturity Extensions, Supporting Refinancing Efforts
NEW YORK--(BUSINESS WIRE)--The Arena Group Holdings, Inc. (NYSE: AREN) (“The Arena Group” or “the Company”), the brand, data and IP company home to iconic brands such as TheStreet, Parade, Men's Journal, Athlon Sports, ShopHQ and more, today announced that it has entered into agreements with its lenders to extend the maturity dates of two existing debt facilities, providing additional flexibility as the Company continues to advance its refinancing plans. Specifically, the Company has extended t.
fool.com
Agnico Eagle Mines: A 7.1 Rating in the Gold Mining Arena
Explore the exciting world of Agnico Eagle Mines (AEM 1.34%) with our contributing expert analysts in this Motley Fool Scoreboard episode. Check out the video below to gain valuable insights into market trends and potential investment opportunities!
seekingalpha.com
The Arena Group Holdings, Inc. (AREN) Shareholder/Analyst Call Prepared Remarks Transcript
The Arena Group Holdings, Inc. (AREN) Shareholder/Analyst Call Prepared Remarks Transcript
prnewswire.com
Atossa Therapeutics Wins 2025 Clinical Trials Arena Research and Development Excellence Award in Precision Endocrine Therapy Category
Recognized for Advancing (Z)-Endoxifen, a Precision-Engineered Endocrine Therapy with Potential Across Multiple Breast Cancer and Rare Disease Settings SEATTLE , Dec. 17, 2025 /PRNewswire/ -- Atossa Therapeutics, Inc. (Nasdaq: ATOS) ("Atossa" or the "Company"), a clinical-stage biopharmaceutical company developing novel therapies in oncology and other areas of high unmet clinical need, announces that it has been selected as a winner of the 2025 Clinical Trials Arena Excellence Awards. The Company was honored with the Research and Development Award in the Precision Endocrine Therapy category.
businesswire.com
Kairos Pharma Wins 2025 Clinical Trials Arena Research and Development Excellence Award for Advanced Prostate Cancer
LOS ANGELES--(BUSINESS WIRE)--Kairos Pharma Ltd. (NYSE American: KAPA), a clinical-stage biopharmaceutical company focused on innovative cancer therapeutics, today announced that it has been selected as a winner of the 2025 Clinical Trials Arena Excellence Awards, receiving the Research and Development Award for Advanced Prostate Cancer. Kairos earned this recognition for its work advancing ENV‑105 (carotuximab), a first‑in‑class CD105‑targeting monoclonal antibody designed to modulate resistan.
globenewswire.com
Jeffs' Brands: KeepZone AI Successfully Completes Live Pilot Demonstrating Checkpoint-Free Weapon Screening at High-Profile Event
Tel Aviv, Israel, Dec. 17, 2025 (GLOBE NEWSWIRE) -- Jeffs' Brands Ltd (“Jeffs' Brands” or the “Company”) (Nasdaq: JFBR, JFBRW), a data-driven e-commerce company operating on the Amazon Marketplace, which recently began expanding into the global homeland security sector through advanced AI-driven solutions, today announced that its wholly owned subsidiary, KeepZone AI Inc. (“KeepZone”), has successfully completed a live operational security technology pilot of Scanary Ltd.'s (“Scanary”) next-generation concealed weapon detection system (the “System”), at Pais Arena Jerusalem (the “Arena”) during a high-profile concert event held on December 10 and 11, 2025.